Abbott Laboratories vs. Eledon Pharmaceuticals, Inc. Common Stock
ABT
Abbott Laboratories
$116.64 +2.19%
VS ELDNEledon Pharmaceuticals, Inc. Common Stock
$3.45 -1.99%
Abbott Laboratories and Eledon Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | ELDN | |
|---|---|---|
| Market Cap | $197.51 billion | $286.04 million |
| Revenue (TTM) | $46.59 billion | — |
| Net Income (TTM) | $5.42 billion | — |
ABT leads on 1 of 1 size & scale factors.
Valuation
| ABT | ELDN | |
|---|---|---|
| P/E Ratio | 37.75 | — |
| Price / Book | 3.82 | — |
| Price / Sales | 4.24 | — |
ABT and ELDN split the valuation factors evenly.
Profitability
| ABT | ELDN | |
|---|---|---|
| Net Margin | 11.65% | — |
| Return on Equity | 10.48% | — |
ABT and ELDN split the profitability factors evenly.
Dividend
| ABT | ELDN | |
|---|---|---|
| Dividend Yield | 2.16% | — |
| Payout Ratio | 81.55 | — |
ABT and ELDN split the dividend factors evenly.
Risk & Sentiment
| ABT | ELDN | |
|---|---|---|
| Short Interest | 0.57% | 0.11% |
ELDN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, ELDN overview, ELDN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.